The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.
From the Pró‐Sangue Foundation, São Paulo, Brazil; Blood Systems Research Institute, San Francisco, California; Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil; Westat, Rockville, Maryland; the University of São Paulo, Sao Paulo, Brazil; and Hemope Foundation, Recife, Pernambuco, Brazil.